Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-123,500
Closed -$2.84M – 5362
2023
Q4
$2.84M Buy
+123,500
New +$2.38M ﹤0.01% 2621
2023
Q1
– Sell
-127,920
Closed -$3.44M – 5347
2022
Q4
$3.44M Buy
+127,920
New +$4.48M ﹤0.01% 1888
2022
Q1
– Sell
-1,950
Closed -$137K – 5597
2021
Q4
$137K Hold
1,950
– – ﹤0.01% 3664
2021
Q3
$220K Hold
1,950
– – ﹤0.01% 3568
2021
Q2
$353K Hold
1,950
– – ﹤0.01% 3274
2021
Q1
$443K Sell
1,950
-16,260
-89% -$3.81M ﹤0.01% 3252
2020
Q4
$1.5M Hold
18,210
– – ﹤0.01% 2468
2020
Q3
$883K Sell
18,210
-200
-1% -$13.4K ﹤0.01% 2799
2020
Q2
$1.31M Sell
18,410
-76,410
-81% -$6.16M ﹤0.01% 2512
2020
Q1
$6.52M Buy
94,820
+33,040
+53% +$4.61M 0.01% 1268
2019
Q4
$10.6M Buy
61,780
+16,360
+36% +$3.38M 0.01% 1360
2019
Q3
$11.2M Buy
45,420
+11,940
+36% +$4.35M 0.01% 1212
2019
Q2
$15.6M Buy
33,480
+14,990
+81% +$7.16M 0.01% 1076
2019
Q1
$12.1M Buy
18,490
+10
+0.1% +$7.63K 0.01% 1116
2018
Q4
$13M Buy
18,480
+9,430
+104% +$10.3M 0.01% 999
2018
Q3
$13M Buy
+9,050
New +$5.82M 0.01% 1106

Other funds holding TLRY

Barclays's TLRY Position: Q3 2026 in Review

Barclays increased its Tilray (TLRY) stake by 80% in Q3 2026, buying an estimated $142K and bringing the position to 73,401 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #3782.

Barclays first reported a position in TLRY in Q3 2018 and has held it in 28 quarters since. The position peaked at $6.71M in Q1 2021. 180 funds tracked by Wall St. Rank hold TLRY as of Q3 2026.

  • Barclays held 73,401 shares of Tilray worth $275K as of Q3 2026.
  • Barclays bought 32,600 Tilray shares in Q3 2026, an estimated $142K.
  • Tilray made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3782 holding.
  • Barclays first reported a position in Tilray in Q3 2018 and has held it in 28 quarters since.
  • Barclays's Tilray position peaked at $6.71M in Q1 2021.
  • 180 funds tracked by Wall St. Rank held Tilray as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.